Sergey Vasnetsov - 01 Mar 2023 Form 4 Insider Report for ASP Isotopes Inc. (ASPI)

Reporting relationship: Director
Issuer ticker: ASPI
Reported as of: 01 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Mar 2023, 15:05:51 UTC
Prior SEC filing: 22 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Sergey Vasnetsov

Key filing fact

Sergey Vasnetsov filed Form 4 for ASP Isotopes Inc. (ASPI) on 08 Mar 2023.

Key facts

This page summarizes Sergey Vasnetsov's Form 4 filing for ASP Isotopes Inc. (ASPI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 08 Mar 2023, 15:05.

Change

Previous filing in this sequence was filed on 22 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ASPI transaction

Common Stock

Award

Transaction value: $0
Shares: +538,607
Change %: +16%
Price: $0.000000
Shares after: 3,838,607
Date: 01 Mar 2023
Ownership: See footnote
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On March 1, 2023, the Company granted 538,607 shares of the Company's restricted common stock to ChemBridges LLC, a Puerto Rico limited liability company controlled by our director, Sergey Vasnetsov, as its manager, pursuant to a second amended Advisory Agreement dated December 12, 2022. 134,651 shares of the common stock vest on each June 1, 2023, September 1, 2023, December 1, 2023 and March 1, 2024.

Footnote F2

Mr. Vasnetsov beneficially owns 1,000,000 common shares indiretly through Elista LLC and beneficially owns 2,838,607 common shares and indirectly through ChemBridges LLC.